borderline significantp = 0.050
Our next analysis suggested that metronidazole treatment in CDI is significantly associated with a lower recurrence rate ( p = 0.001), while it also showed a trend toward improved outcomes and reduced mortality, although these associations were borderline significant ( p = 0.050).